Lakewood-Amedex Biotherapeutics Inc. (LABT) Stock buybacks
Lakewood-Amedex Biotherapeutics Inc. (LABT) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$50,000FY2024
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $50,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LABT financial trends
LABT RevenueLABT Net incomeLABT Net marginLABT Gross profitLABT Gross marginLABT Operating incomeLABT Operating marginLABT Operating cash flowLABT Free cash flowLABT Capital expendituresLABT Return on equityLABT Dividends paidLABT Total assetsLABT Total liabilitiesLABT Shareholders’ equityLABT overview →